Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of medicine / 醫學系
  4. Synthesis of Novel [60]Fullerene-Pirfenidone---A Selective Delivery of Antifibrotic Agents to Liver
 
  • Details
Options

Synthesis of Novel [60]Fullerene-Pirfenidone---A Selective Delivery of Antifibrotic Agents to Liver

Other Title
設計與開發[60]Fullerene-Pirfenidone 為肝臟的特定抗發炎藥物運送分子
Type
report
Date Issued
2004
Author(s)
黃聲東
Subjects
學科:生物化學暨細胞分子生物學科
計畫報告
URI
https://203.71.86.71/handle/123456789/30946
File(s)
Loading...
Thumbnail Image
Name

attachment.pdf

Size

187.16 KB

Format

Adobe PDF

Checksum

(MD5):a6f119d087d9331e6999de96ac5efe5a

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback